Nutropin Depot (Somatropin (rDNA)) Growth Hormone Available In The US
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Nutropin Depot (Somatropin (rDNA)) Growth Hormone Available In The US

SOUTH SAN FRANCISCO, CA and CAMBRIDGE, MA -- June 29, 2000 -- Genentech, Inc. and Alkermes, Inc. announced that Nutropin Depot™ (somatropin (rDNA) for injectable suspension) -- the first long-acting dosage form of recombinant human growth hormone -- is now being shipped to the pediatric endocrine community in the United States. Nutropin Depot was approved by the U.S. Food and Drug Administration (FDA) on December 23, 1999.

Nutropin Depot is a long-acting form of Genentech's human growth hormone using Alkermes' ProLease® injectable extended-release drug delivery system. Alkermes performs the manufacturing operations that convert Genentech's Nutropin (somatropin (rDNA origin) for injection) bulk product into the long-acting dosage form. Genentech will market the product in the United States.

Related Links: Genentech, Inc. and Alkermes, Inc.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities